<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04885595</url>
  </required_header>
  <id_info>
    <org_study_id>2021-00323</org_study_id>
    <nct_id>NCT04885595</nct_id>
  </id_info>
  <brief_title>Diagnosis of Peripheral Lung Nodules Using Cryobiopsy</brief_title>
  <acronym>Cryo-Nodule</acronym>
  <official_title>Bronchoscopic Diagnosis of Peripheral Lung Nodules Using Endobronchial Ultrasound Guided Forceps and Cryobiopsy. A Randomized-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since the traditional radial endobronchial ultrasound guided biopsy technique of solitary&#xD;
      pulmonary nodules using the forceps has several shortcomings, the purpose of this study is to&#xD;
      investigate a new biopsy technique using the transbronchial cryobrobe&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomized trial to assess diagnostic accuracy and safety of cryobiopsy&#xD;
      using two different outer diameters. Included patients are 1:1 randomized to receive forceps&#xD;
      biopsy following cryobiopsy with a 1.1mm or 1.7mm cryoprobe.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Actual">April 7, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic yield</measure>
    <time_frame>up to 1 month</time_frame>
    <description>The diagnostic yield of the malign lesions that we were able to visualise with EBUS in percentage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Size of harvested tissue in millimeter</measure>
    <time_frame>up to 1 month</time_frame>
    <description>The biopsies are assessed for total size in millimeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Size of malign tissue in millimeter</measure>
    <time_frame>up to 1 month</time_frame>
    <description>The biopsies are assessed for size of malign tissue in milimeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of bleeding events</measure>
    <time_frame>up to 1 month</time_frame>
    <description>Occurrence of bleeding events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Size of artifact-free alvoelar space in percentage</measure>
    <time_frame>up to 1 month</time_frame>
    <description>Size of artifact-free alvoelar space in percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radial endobronchial utrasound probe orientation (excentric, concentric, adjacent)</measure>
    <time_frame>1 day</time_frame>
    <description>Lesion orientation with regards of the radial endobronchial ultrasound probe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurence of pneumothorax</measure>
    <time_frame>up to 1 month</time_frame>
    <description>Detection with X-ray</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Lung; Node</condition>
  <arm_group>
    <arm_group_label>Forceps-Cryo 1.1 mm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Forceps biopsy following cryobiopsy with a 1.1mm cryoprobe are obtained within the same session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Forceps-Cryo 1.7 mm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Forceps biopsy following cryobiopsy with a 1.7mm cryoprobe are obtained within the same session</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Forceps biopsy and cryobiopsy</intervention_name>
    <description>Once the nodule is visualized by radial EBUS, the position of the probe in relation to the lesion is noted. Routinely, forceps biopsy and cryobiopsy are used serially in each patient within the same session.</description>
    <arm_group_label>Forceps-Cryo 1.1 mm</arm_group_label>
    <arm_group_label>Forceps-Cryo 1.7 mm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Solitary pulmonary nodule with indication of bronchoscopic diagnostic approach&#xD;
&#xD;
          -  Age between 18 and 90 years&#xD;
&#xD;
          -  Written informed consent after participant's information&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 and &gt; 90 years&#xD;
&#xD;
          -  Lacking ability to form an informed consent (including impaired judgement,&#xD;
             communi-cation barriers)&#xD;
&#xD;
          -  Contraindication against bronchoscopy (e.g. co-morbidities)&#xD;
&#xD;
          -  INR &gt; 2 or Thrombocytes &lt; 50000&#xD;
&#xD;
          -  Double antiplatelet drugs (e.g. ASS and Clopidogrel) within 7 days before biopsy&#xD;
&#xD;
          -  Anticoagulation with NOAK within 48 hours before biopsy&#xD;
&#xD;
          -  Moderate or severe pulmonary hypertension (mPAP &gt; 30 mmHg, RV/RA &gt;30 mmHg)&#xD;
&#xD;
          -  Tumors suspicious of endobronchial growth&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carolin Steinack, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 18, 2021</study_first_submitted>
  <study_first_submitted_qc>May 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>May 8, 2021</last_update_submitted>
  <last_update_submitted_qc>May 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Carolin Steinack</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cryobiopsy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

